Belgium's forecast for malignant neoplasms mortality among men indicates a decline from 2024's rate of 220.3 deaths per hundred thousand standardized to 197.6 by 2028. This marks a decrease of roughly -10.3% over four years, with specific year-on-year declines of -2.7% (2024-2025), -2.7% (2025-2026), -2.7% (2026-2027), and -2.7% (2027-2028). For reference, the 2023 mortality rate stood at 226.7 deaths per hundred thousand standardized.
Key future trends to watch for include advancements in medical treatments, early detection technologies, lifestyle changes, and public health policy improvements. These factors will likely contribute to the ongoing decline in mortality rates and better overall healthcare outcomes.
